Drugs / TD Vaccine System
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT01040325 Comparator | Dec 2009 → Jun 2010 | acute diarrhea | Intercell USA, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00993681 Comparator | Oct 2009 → Nov 2010 | acute diarrhea | Intercell USA, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TD Vaccine System | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01040325 ↗ |
| Modality | Vaccine | “a skin-patch vaccine containing the pathogen's heat-labile toxin (LT)” PMID 24291168 ↗ Nov 2013 |
| Route | Other | “receive transcutaneous immunisation with a patch containing 37.5 μg of ETEC LT” PMID 24291168 ↗ Nov 2013 |